APLS vs SHW · rev $1.00B vs P/E 29, rev $12.46B
Apellis Pharmaceuticals Inc (APLS) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
APLS currently screens at market cap $2.29B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the APLS and SHW stock pages for the full models.
Not investment advice.